Contact information
Kezia Gaitskell
BM BCh MA (Oxon) MSc DPhil FRCPath
Consultant Pathologist and Honorary Senior Clinical Lecturer
Dr Kezia Gaitskell is an Honorary Senior Clinical Lecturer in the Nuffield Division of Clinical Laboratory Sciences (NDCLS) and a Locum Consultant in Histopathology at Oxford University Hospitals. She graduated with distinction from Oxford University Medical School in 2008, and undertook Academic Foundation Training in London, before studying for an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine (graduating with distinction). She worked as a histopathology trainee in London, and completed a DPhil in Population Health in the Oxford University Cancer Epidemiology Unit (funded by Cancer Research UK), before taking up a post as an NIHR-funded Academic Clinical Lecturer in 2018. In 2022 she completed her clinical training and began work as a consultant, alongside continuing research and teaching.
Her main research interest is at the junction of epidemiology and pathology, in collaboration with the Nuffield Department of Population Health. For her DPhil, she explored risk factors for ovarian cancer, and their variation by histological type, supervised by Professor Dame Valerie Beral, and Professor Ahmed A. Ahmed. Her current work continues to investigate factors associated with cancer incidence and survival, and how these associations vary by tumour histotype.
Key publications
-
Ovarian cancer survival by stage, histotype, and pre-diagnostic lifestyle factors, in the prospective UK Million Women Study
Journal article
Gaitskell K. et al, (2022), Cancer Epidemiology, 76, 102074 - 102074
-
Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.
Journal article
Gaitskell K. et al, (2018), Int J Cancer, 142, 281 - 289
-
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.
Journal article
Collaborative Group On Epidemiological Studies Of Ovarian Cancer None. et al, (2015), Lancet, 385, 1835 - 1842
-
Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.
Journal article
Collaborative Group on Epidemiological Studies of Ovarian Cancer None. et al, (2012), Lancet Oncol, 13, 946 - 956
-
Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
Journal article
Gaitskell K. et al, (2016), Int J Cancer, 138, 1076 - 1084
-
Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.
Journal article
Gaitskell K. et al, (2016), Br J Cancer, 114, 1033 - 1037
-
Angiogenesis inhibitors for the treatment of ovarian cancer.
Journal article
Gaitskell K. et al, (2011), Cochrane Database Syst Rev
-
Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
Journal article
Burón Pust A. et al, (2017), Int J Cancer, 140, 1082 - 1090
Recent publications
-
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Journal article
Nistor S. et al, (2023), Transl Cancer Res, 12, 2682 - 2692
-
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer
Journal article
Gaitskell K. et al, (2023), Cochrane Database of Systematic Reviews, 2023
-
Ovarian cancer survival by stage, histotype, and pre-diagnostic lifestyle factors, in the prospective UK Million Women Study
Journal article
Gaitskell K. et al, (2022), Cancer Epidemiology, 76, 102074 - 102074
-
Predicting Molecular Traits from Tissue Morphology Through Self-interactive Multi-instance Learning
Conference paper
Hu Y. et al, (2022), Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 13432 LNCS, 130 - 139